USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
Introduction. Women with infertility and circulating antiphospholipid antibodies (APA) may be at risk of reproductive losses. A possible way to improve their in vitro fertilization (IVF) outcomes is the immunomodulating therapy using intravenous immunoglobulin (IVIG). Aim: to study the effecacy...
Main Authors: | M. I. Krivonos, M. S. Zainulina, E. A. Kornyushina, S. V. Chepanov, S. A. Selkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2017-12-01
|
Series: | Акушерство, гинекология и репродукция |
Subjects: | |
Online Access: | https://www.gynecology.su/jour/article/view/423 |
Similar Items
-
Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
by: Ekaterina Sergeevna Orlova, et al.
Published: (2019-08-01) -
IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01) -
ANTIPHOSPHOLIPID SYNDROME AND EARLY REPRODUCTIVE FAILURE
by: M. I. Krivonos, et al.
Published: (2017-03-01) -
CIRCULATION OF ANTIPHOSPHOLIPID ANTIBODIES AND IVF FAILURES
by: N. S. Stuleva, et al.
Published: (2016-06-01) -
Antiphospholipid Antibody Syndrome and Infertility
by: Vivian de Oliveira Rodrigues, et al.
Published: (2019-11-01)